logo

1.07

1.07 (0.15%)

As of Jun 14, 2022

Protalix Biotherapeutics, Inc. [PLX]

Source: 

Company Overview

Protalix Biotherapeutics, Inc. is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by our proprietary ProCellEx® plant cell-based protein expression system. We are the first and only company to gain FDA approval of a protein produced through plant cell-based expression in suspension.

CountryUS
Headquartershackensacknew jersey
Phone Number201-696-9345
Industry
manufacturing
CEODror Bashan
Websitehttp://www.protalix.com

Related Stories